Sponsor Pipeline

BioCryst Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04933721 Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies Hereditary Angioedema Enrolling by Invitation
NCT05453968 Berotralstat Treatment in Children With Hereditary Angioedema Hereditary Angioedema Active, Not Recruiting
Phase 1
NCT06539507 A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 Netherton Syndrome Recruiting
Get alerts when BioCryst Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free